92 related articles for article (PubMed ID: 20540020)
1. [Kidney transplant: a mere stage of CKD?].
Frascà GM; Balestra E; Gaffi G; Taruscia D; Freddi P; D'Arezzo M; Sagripanti S; Nastasi V
G Ital Nefrol; 2010; 27(3):274-81. PubMed ID: 20540020
[TBL] [Abstract][Full Text] [Related]
2. The Bergamo Kidney Transplant Program.
Perico N; Cravedi P; Ruggenenti P; Gotti E; Rota G; Locatelli G; Gambara V; Perna A; Rota S; Remuzzi G
Clin Transpl; 2005; ():85-100. PubMed ID: 17424727
[TBL] [Abstract][Full Text] [Related]
3. Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.
Marcén R; del Castillo D; Capdevila L; Fernandez-Fresnedo G; Rodrigo E; Cantarell C; Fernández-Rodriguez A; López-Oliva MO; Camps J; Aljama P; Ortuño J; Arias M
Transplantation; 2009 May; 87(9):1340-6. PubMed ID: 19424034
[TBL] [Abstract][Full Text] [Related]
4. Renal disease in recipients of nonrenal solid organ transplantation.
Ojo AO
Semin Nephrol; 2007 Jul; 27(4):498-507. PubMed ID: 17616280
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
[TBL] [Abstract][Full Text] [Related]
6. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
7. Renal function: defining long-term success.
Pascual J; Marcén R; Ortuño J
Nephrol Dial Transplant; 2004 Dec; 19 Suppl 6():vi3-vi7. PubMed ID: 15575023
[TBL] [Abstract][Full Text] [Related]
8. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
9. Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis.
Ibels LS; Stewart JH; Mahony JF; Neale FC; Sheil AG
Q J Med; 1977 Apr; 46(182):197-214. PubMed ID: 325593
[TBL] [Abstract][Full Text] [Related]
10. Outcomes after liver transplantation: chronic kidney disease.
Bahirwani R; Reddy KR
Liver Transpl; 2009 Nov; 15 Suppl 2():S70-4. PubMed ID: 19876956
[TBL] [Abstract][Full Text] [Related]
11. [Post-transplant nephropathy and arterial hypertension].
Oko A; Idasiak-Piechocka I; Czekalski S
Przegl Lek; 2001; 58(9):859-63. PubMed ID: 11868248
[TBL] [Abstract][Full Text] [Related]
12. Management of renal dysfunction in the liver transplant recipient.
Pham PT; Pham PC; Wilkinson AH
Curr Opin Organ Transplant; 2009 Jun; 14(3):231-9. PubMed ID: 19395967
[TBL] [Abstract][Full Text] [Related]
13. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
[TBL] [Abstract][Full Text] [Related]
14. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
15. Bone metabolism according to chronic kidney disease stages in patients undergoing kidney transplantation: a 5-year database analysis.
Fernández-Fresnedo G; Rodrigo E; Ruiz JC; Martín de Francisco AL; Arias M
Transplant Proc; 2009; 41(6):2403-5. PubMed ID: 19715933
[TBL] [Abstract][Full Text] [Related]
16. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
17. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
[TBL] [Abstract][Full Text] [Related]
19. Chronic kidney disease in renal transplant recipients.
Marcén R; Pascual J; Tenorio M; Ocaña EJ; Teruel JL; Villafruela JJ; Fernández M; Burgos FJ; Ortuño J
Transplant Proc; 2005 Nov; 37(9):3718-20. PubMed ID: 16386516
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic allograft dysfunction by switch over to rapamycin.
Sundaram V; Abraham G; Fathima N; Sundaram V; Reddy YN; Mathew M; Sathiah V
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):37-42. PubMed ID: 20061690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
